These observations indicate that cisplatin might promote abnormal repair in AKI, and the small number of BrdU+ cells detected in the SIRT3 KO cisplatin-treated mouse kidneys suggests that SIRT3 deficiency likely inhibits cell regeneration by preventing the entry of cells into the S phase. Here, SIRT3 is linked to acute kidney injury.